Pcas SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pcas SA with three other
pharmaceutical manufacturers in Europe:
sales of 164.51 million Euro [US$184.63 million]
of which 84%
was EVT Execute),
Deva Holding AS
(688.46 million Turkish Liras [US$193.37 million]
of which 93%
was Pharmaceuticals), and
based in Turkey
(678.26 million Turkish Liras [US$190.50 million]
During the year ended December of 2016, sales at
Pcas SA were 192.00 million Euro (US$215.49 million).
increase of 7.2%
versus 2015, when the company's sales were 179.09 million Euro.
This was the third consecutive year of growth at Pcas SA.